window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 30, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Biotech & Pharma Business

  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Syngene collaborates with Johns Hopkins University to advance early-stage drug discovery

    Syngene International has entered a collaboration with Johns Hopkins University [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    IgniteData appoints Laura Hilty as CSO and Joe Lengfellner as CPO amid Series A funding close

    IgniteData has appointed Laura Hilty as chief strategy officer and [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Hans Schambye appointed as CEO of BOOST Pharma as BT‑101 advances toward Phase 3

    BOOST Pharma has appointed Hans Schambye as its new chief [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    SPT Labtech and BellBrook Labs unveil high-throughput screening platform targeting VPS4B in cancer research

    SPT Labtech and BellBrook Labs have introduced a miniaturised high-throughput [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas

    BNPP AM Alts invests $115M in ILiAD Biotechnologies to advance whooping cough vaccine

    BNP Paribas Asset Management Alts (BNPP AM Alts) has made [...]

    May 5, 2026
  • Biotech & Pharma Business,Pharmaceuticals and therapeutics,Therapeutic Areas

    Kainova Therapeutics raises $32m CAD Series B to advance immuno-oncology and inflammation pipeline

    Kainova Therapeutics has secured $32m CAD in a Series B [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    5 Insights on Data Foundations From Top Pharma Leaders

    As the pharmaceutical industry moves from AI experimentation to execution, [...]

    May 5, 2026
  • Biotech & Pharma Business,Pharmaceuticals and therapeutics

    Juvisé Pharmaceuticals secures €550m refinancing led by Hayfin Capital Management

    Juvisé Pharmaceuticals has completed a €550m refinancing transaction led by [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Therapeutic Areas

    Evogene licenses microbiome cancer therapy BMC128 to Shanghai Lishan Biopharmaceuticals

    Evogene and Shanghai Lishan Biopharmaceuticals have entered into an exclusive [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Therapeutic Areas

    NeoVac reports Phase 1 and Phase 2 data for NeomiVac mRNA LNP covid-19 vaccine

    NeoVac has reported positive first-in-human Phase 1 and Phase 2 [...]

    May 5, 2026
Previous8910Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Currax highlights peer-reviewed review supporting combination approaches in obesity treatment
    Categories: Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
  • MaaT Pharma publishes real-world CHRONOS data in third-line acute GvHD
    Categories: Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
  • Symbiosis expands QC capabilities with new 30°C stability chamber
    Categories: Manufacturing & Supply Chain, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top